Safety and Efficacy of Silk Vista and Silk Vista Baby Flow Diverter for Intracranial Aneurysm Treatment (FIRST)
Safety and Efficacy of Silk Vista and Silk Vista Baby Flow Diverter for Intracranial Aneurysm Treatment, an Observational, Prospective, Single Arm, International, Multicenter Study.
Sponsor: Balt Extrusion
Listed as NCT04034810, this observational or N/A phase trial focuses on Flow Diverter and Intracranial Aneurysm and remains ongoing. Sponsored by Balt Extrusion, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting
-
Sep 2025 — Oct 2025 [monthly]
Active Not Recruiting
-
Sep 2024 — Sep 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Mar 2023 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 4 earlier versions
-
Jan 2021 — Mar 2023 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
-
Feb 2020 — Dec 2020 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Aug 2019 — Feb 2020 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Balt Extrusion
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Barakaldo, Spain , Bordeaux, France , Brest, France , Bron, France , Caen, France , Clermont-Ferrand, France , Grenoble, France , Jerusalem, Israel , Le Kremlin-Bicêtre, France , Limoges, France and 17 more locations